Journal Article Review Epublish 6 citations
PubMed: 40662045 DOI: 10.7759/cureus.85813
Cardiovascular-Renal-Hepatic-Metabolic Syndrome: Interlinked Pathophysiology and Integrated Management Approach.
Cureus 17(6):e85813
Authors: Carlos Alejandro Arragan Lezama, Julio Joel Jaramillo Ramos, David Alejandro Armas Eguizábal, Ximena Sofía Solares Ovando, Julio Cesar Minera Villagrán, Cinthya Jhoana Males Caiza
Affiliations
- General Practice, Universidad Anáhuac Xalapa, Veracruz, MEX.
- Internal Medicine, Hospital Santo Tomás, Panama City, PAN.
- Internal Medicine, Centro Médico Guatemala, Guatemala, GTM.
- Internal Medicine, Centro Médico Militar, Guatemala, GTM.
- Oncology, Instituto Guatemalteco de Seguridad Social, Guatemala, GTM.
- General Practice, Universidad Nacional de Chimborazo, Otavalo, ECU.
Abstract
Interdisciplinary research has revealed that heart, kidney, liver, and metabolic diseases share interlinked pathological mechanisms, including inflammation, oxidative stress, insulin resistance, and endothelial health issues. However, integrated care for these diseases is challenging due to different symptoms, diagnostic rules, and treatment options. The review aims to study the common mechanisms behind cardiovascular-renal-hepatic-metabolic syndrome and explore ways to coordinate management. When these systems work poorly together, damage can form a vicious cycle, increasing hypertension, chronic kidney disease, non-alcoholic fatty liver disease, and metabolic syndrome. Changes in medicine, daily lifestyle, and drugs can interrupt the pathological cascade. However, clinical practice is hindered by patient presentations, lack of teamwork across healthcare specialties, and incomplete therapy plans. Gut-organ axis dysfunction and inflammation play a significant role in multiple organ diseases, and prompt risk assessment and early intervention can prevent heart damage.
MeSH
Heart, Kidney, Liver, Work, Therapeutics, Metabolic Syndrome